NoureldineHAEl HasbaniGNour EldineM, et al.Postural tachycardia syndrome (POTS) and antiphospholipid syndrome (APS): what do we know so far?Rev Neurol2022; 178: 306–314.
2.
ZeeKQureshiS. POTS and antiphospholipid syndrome: an unlikely association. Case Rep Rheumatol2021; 2021: 9942668.
3.
SchofieldJRBlitshteynSShoenfeldY, et al.Postural tachycardia syndrome (POTS) and other autonomic disorders in antiphospholipid (Hughes) syndrome (APS). Lupus2014; 23: 697–702.
4.
BlitshteynS. Autoimmune markers and autoimmune disorders in patients with postural tachycardia syndrome (POTS). Lupus2015; 24: 1364–1369.
5.
GunningWTKvaleHKramerPM, et al.Postural orthostatic tachycardia syndrome is associated with elevated g‐protein coupled receptor autoantibodies. J Am Heart Assoc2019; 8: e013602.
6.
SchofieldJR. Autonomic Neuropathy—in its many guises—As the initial manifestation of the antiphospholipid syndrome. Immunol Res2017; 65: 532–542.
7.
MathiasCJLowDAIodiceV, et al.Postural tachycardia syndrome—current experience and concepts. Nat Rev Neurol2012; 8: 22–34.
8.
MannanHPainCM. Sex adjusted standardized prevalence ratios for celiac disease and other autoimmune diseases in patients with postural orthostatic tachycardia syndrome (POTS): a systematic review and meta-analysis. Heliyon2023; 9: e12982.
9.
StilesLBorisJR. New ICD-10 code for POTS. 2022.
10.
GarciaCPerandiniLASeguroLPC, et al.Impaired aerobic exercise capacity and cardiac autonomic control in primary antiphospholipid syndrome. Lupus2013; 22: 928–931.
